HeartBeam, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Latest news
All BEATW news ›HeartBeam Sets Q3 2026 Earnings Call Amid Key Heart Attack Detection Updates
citybuzz - HeartBeam Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care, has scheduled a conference call for Thursday, Nov. 12, 2026, at 4:30 p.m. ET to discuss its financial results for
HeartBeam to Host Third Quarter 2026 Results Conference Call on Thursday, November 12, 2026 at 4:30 p.m. Eastern Time
HeartBeam Executive Chairman Richard Ferrari, President and Founder Branislav Vajdic, Ph.D., and Chief Financial Officer Timothy Cruickshank will host the conference call, followed b
HeartBeam reports higher ECG specificity in 132‑patient heart attack pilot
Sensitivity was slightly lower than standard ECGs; a U.S. pivotal study is planned for the first quarter of 2027. A patient-recorded ECG achieved higher specificity but slightly lower sensitivity than a standard recording as HeartBeam,…
HeartBeam’s ALIGN-ACS Pilot Study Shows Higher Specificity Than Standard ECG for Heart Attack Assessment
HeartBeam's ALIGN-ACS Pilot Study Shows Higher Specificity Than Standard ECG for Heart Attack Assessment citybuzz - HeartBeam Inc. (NASDAQ: BEAT), a medical technology company focused on cardiac monitoring and detection, reported positive…
HeartBeam's Heart Attack Assessment Technology Accepted into FDA's Total Product Life Cycle Advisory Program (TAP)
(NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced that the U.S. Food and Drug Administration (FDA) has accepted ... HeartBeam's Heart Attack Assessment…
HeartBeam (NASDAQ:BEAT) Stock Breaks Above 50-Day Moving Average – Time to Sell?
Posted by Mitch Edgeman on Oct 31st, 2026 HeartBeam, Inc. (NASDAQ:BEAT – Get Free Report)’s share price passed above its fifty day moving average during trading on Wednesday. The stock has a fifty day moving average of $0.44 and traded as…
HeartBeam Joins European EXIT-CVD Research Consortium to Advance At-Home ECG Monitoring for Early Detection of Acute Coronary Syndrome (ACS) in High-Risk Patients
Within EXIT-CVD, the HEART-CHECK study will evaluate the HeartBeam System for early detection and triage of cardiac events in high-risk patients recently discharged after an acute coronary syndrome (ACS), a group with well-documented risk…
HEADSTART-ACS Completes Enrollment Ahead of Schedule, the Largest Heart Attack Detection Study to Date Using HeartBeam Technology
BioSpace HEADSTART-ACS Completes Enrollment Ahead of Schedule, the Largest Heart Attack Detection Study to Date Using HeartBeam Technology - HEADSTART-ACS study conducte
HeartBeam Joins European Consortium to Lead HEART-CHECK Study
citybuzz - HeartBeam Inc. (NASDAQ: BEAT), a medical technology company focused on cardiac care, announced its participation as a contributing partner in the launch of EXIT-CVD, a European cardiovascular research initiative co-funded by th
HeartBeam (NASDAQ:BEAT) Upgraded at Wall Street Zen
Posted by Kim Johansen on Oct 13th, 2026 Wall Street Zen upgraded shares of HeartBeam (NASDAQ:BEAT – Free Report) to a sell rating in a research note issued to investors on Saturday morning,Wall Street Zen reports. Get Our Latest Analysis…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- stocktitan.net8
- mugglehead.com2
- themarketsdaily.com2
- businesswire.com1
- coincentral.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 16 articles, not a forecast.